Latest News on Drug Pricing
Showing of 0 - 10 from 7 results
Drug Pricing - Total results - 7
Feb 06, 2019
Fact check: Trump exaggerated economic boom in State of Union speech; economy healthy but not nearly one of the bestThe Associated Press is fact-checking remarks from US president Donald Trump's State of the Union speech. Here's a look at some of the claims we've examined
Sep 26, 2014
Why the Modi government's rollback of drug price control is worryingly anti-peopleWhile civil society and access-to-medicine activists demand for more such price controls, the government has removed the price controlling powers of the National Pharmaceutical Pricing Authority (NPPA).
Sep 25, 2014
Didn't withdraw drug price regulator's powers with order, says govtThe government said that the only internal guidelines issued by the drug price regulator to cap prices of non-scheduled drugs have been rolled back
Sep 23, 2014
Govt takes away regulator's powers to fix prices of non-essential drugs in futureIndia's decision to withdraw the drug pricing authority's powers to fix the prices of non-essential medicines will be on a prospective basis, and will not affect price caps imposed in July on 108 drugs, a senior government official said on Tuesday.
Sep 18, 2014
No end to its troubles: US now seeks drug pricing details from RanbaxyRanbaxy Laboratories today said the US Department of Justice has demanded information relating to the manner in which the company reports pricing data for certain products eligible for reimbursement under the Medicaid program.
Jul 16, 2014
Not just price caps: Here's how the govt can make essential drugs more affordableThe recent price cut of 108 drugs by the National Pharmaceutical Pricing Authority (NPPA) is a bold step in expanding people's access to essential medicines after the UPA government slashed prices of 348 drugs in 2012.
Oct 03, 2013
SC raises ceiling price question on new Drug price Control OrderThe Supreme Court today raised a question on the new Drug Price Control Order (DPCO) of the Centre to fix the ceiling price of essential medicines on the basis of market-based pricing